APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Acquired hemophilia A Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Acquired hemophilia A Drugs Market Analysis and Forecast 2026-2032

Report ID 173959920222 December 2025190 pages

Choose your research edition.

Industry ResearchAcquired hemophilia A Drugs Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Acquired hemophilia A Drugs Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Acquired hemophilia A Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acquired hemophilia A Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Acquired hemophilia A Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Acquired hemophilia A Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Acquired hemophilia A Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Acquired hemophilia A Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Acquired hemophilia A Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Acquired hemophilia A Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Acquired hemophilia A Drugs include Sobi and Sanofi etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Acquired hemophilia A Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Acquired hemophilia A Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Acquired hemophilia A Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acquired hemophilia A Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Acquired hemophilia A Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Acquired hemophilia A Drugs sales, projected growth trends, production technology, application and end-user industry.

Acquired hemophilia A Drugs Segment by Company

Sobi

Sanofi

Acquired hemophilia A Drugs Segment by Type

200IU

250IU

Acquired hemophilia A Drugs Segment by Application

Hospital

Pharmacy

Acquired hemophilia A Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acquired hemophilia A Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acquired hemophilia A Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acquired hemophilia A Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Acquired hemophilia A Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Acquired hemophilia A Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acquired hemophilia A Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acquired hemophilia A Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 200IU Major Manufacturers Table 3. 250IU Major Manufacturers Table 4. Global Acquired hemophilia A Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Acquired hemophilia A Drugs Industry Trends Table 8. Acquired hemophilia A Drugs Industry Drivers Table 9. Acquired hemophilia A Drugs Industry Opportunities and Challenges Table 10. Acquired hemophilia A Drugs Industry Restraints Table 11. Global Acquired hemophilia A Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Acquired hemophilia A Drugs Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Acquired hemophilia A Drugs Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Acquired hemophilia A Drugs Revenue Market Share by Region (2021-2026) Table 15. Global Acquired hemophilia A Drugs Revenue Market Share by Region (2027-2032) Table 16. Global Acquired hemophilia A Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Acquired hemophilia A Drugs Sales by Region (2021-2026) & (k units) Table 18. Global Acquired hemophilia A Drugs Sales by Region (2027-2032) & (k units) Table 19. Global Acquired hemophilia A Drugs Sales Market Share by Region (2021-2026) Table 20. Global Acquired hemophilia A Drugs Sales Market Share by Region (2027-2032) Table 21. Global Acquired hemophilia A Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Acquired hemophilia A Drugs Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Acquired hemophilia A Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Acquired hemophilia A Drugs Sales Market Share by Manufacturers (2021-2026) Table 25. Global Acquired hemophilia A Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Acquired hemophilia A Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Acquired hemophilia A Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Acquired hemophilia A Drugs Manufacturers, Product Type & Application Table 29. Global Acquired hemophilia A Drugs Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Acquired hemophilia A Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Acquired hemophilia A Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Acquired hemophilia A Drugs Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Acquired hemophilia A Drugs Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Acquired hemophilia A Drugs Revenue Market Share by Type (2021-2026) Table 36. Global Acquired hemophilia A Drugs Revenue Market Share by Type (2027-2032) Table 37. Global Acquired hemophilia A Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Acquired hemophilia A Drugs Sales by Type (2021-2026) & (k units) Table 39. Global Acquired hemophilia A Drugs Sales by Type (2027-2032) & (k units) Table 40. Global Acquired hemophilia A Drugs Sales Market Share by Type (2021-2026) Table 41. Global Acquired hemophilia A Drugs Sales Market Share by Type (2027-2032) Table 42. Global Acquired hemophilia A Drugs Price by Type (2021-2026) & (US$/unit) Table 43. Global Acquired hemophilia A Drugs Price by Type (2027-2032) & (US$/unit) Table 44. Global Acquired hemophilia A Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Acquired hemophilia A Drugs Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Acquired hemophilia A Drugs Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Acquired hemophilia A Drugs Revenue Market Share by Application (2021-2026) Table 48. Global Acquired hemophilia A Drugs Revenue Market Share by Application (2027-2032) Table 49. Global Acquired hemophilia A Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Acquired hemophilia A Drugs Sales by Application (2021-2026) & (k units) Table 51. Global Acquired hemophilia A Drugs Sales by Application (2027-2032) & (k units) Table 52. Global Acquired hemophilia A Drugs Sales Market Share by Application (2021-2026) Table 53. Global Acquired hemophilia A Drugs Sales Market Share by Application (2027-2032) Table 54. Global Acquired hemophilia A Drugs Price by Application (2021-2026) & (US$/unit) Table 55. Global Acquired hemophilia A Drugs Price by Application (2027-2032) & (US$/unit) Table 56. Sobi Company Information Table 57. Sobi Business Overview Table 58. Sobi Acquired hemophilia A Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Sobi Acquired hemophilia A Drugs Product Portfolio Table 60. Sobi Recent Development Table 61. Sanofi Company Information Table 62. Sanofi Business Overview Table 63. Sanofi Acquired hemophilia A Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Sanofi Acquired hemophilia A Drugs Product Portfolio Table 65. Sanofi Recent Development Table 66. North America Acquired hemophilia A Drugs Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Acquired hemophilia A Drugs Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Acquired hemophilia A Drugs Sales by Type (2021-2026) & (k units) Table 69. North America Acquired hemophilia A Drugs Sales by Type (2027-2032) & (k units) Table 70. North America Acquired hemophilia A Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 71. North America Acquired hemophilia A Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 72. North America Acquired hemophilia A Drugs Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Acquired hemophilia A Drugs Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Acquired hemophilia A Drugs Sales by Application (2021-2026) & (k units) Table 75. North America Acquired hemophilia A Drugs Sales by Application (2027-2032) & (k units) Table 76. North America Acquired hemophilia A Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 77. North America Acquired hemophilia A Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 78. North America Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Acquired hemophilia A Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 82. North America Acquired hemophilia A Drugs Sales by Country (2021-2026) & (k units) Table 83. North America Acquired hemophilia A Drugs Sales by Country (2027-2032) & (k units) Table 84. North America Acquired hemophilia A Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 85. North America Acquired hemophilia A Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 86. United States Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 87. Canada Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 88. Mexico Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 89. Europe Acquired hemophilia A Drugs Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Acquired hemophilia A Drugs Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Acquired hemophilia A Drugs Sales by Type (2021-2026) & (k units) Table 92. Europe Acquired hemophilia A Drugs Sales by Type (2027-2032) & (k units) Table 93. Europe Acquired hemophilia A Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 94. Europe Acquired hemophilia A Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 95. Europe Acquired hemophilia A Drugs Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Acquired hemophilia A Drugs Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Acquired hemophilia A Drugs Sales by Application (2021-2026) & (k units) Table 98. Europe Acquired hemophilia A Drugs Sales by Application (2027-2032) & (k units) Table 99. Europe Acquired hemophilia A Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 100. Europe Acquired hemophilia A Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 101. Europe Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. Europe Acquired hemophilia A Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. Europe Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 105. Europe Acquired hemophilia A Drugs Sales by Country (2021-2026) & (k units) Table 106. Europe Acquired hemophilia A Drugs Sales by Country (2027-2032) & (k units) Table 107. Europe Acquired hemophilia A Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 108. Europe Acquired hemophilia A Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 109. Germany Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 110. France Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 111. U.K. Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 112. Italy Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 113. Russia Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 114. Spain Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 115. Netherlands Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 116. Switzerland Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 117. Sweden Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 118. Poland Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 119. China Acquired hemophilia A Drugs Revenue by Type (2021-2026) & (US$ Million) Table 120. China Acquired hemophilia A Drugs Revenue by Type (2027-2032) & (US$ Million) Table 121. China Acquired hemophilia A Drugs Sales by Type (2021-2026) & (k units) Table 122. China Acquired hemophilia A Drugs Sales by Type (2027-2032) & (k units) Table 123. China Acquired hemophilia A Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 124. China Acquired hemophilia A Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 125. China Acquired hemophilia A Drugs Revenue by Application (2021-2026) & (US$ Million) Table 126. China Acquired hemophilia A Drugs Revenue by Application (2027-2032) & (US$ Million) Table 127. China Acquired hemophilia A Drugs Sales by Application (2021-2026) & (k units) Table 128. China Acquired hemophilia A Drugs Sales by Application (2027-2032) & (k units) Table 129. China Acquired hemophilia A Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 130. China Acquired hemophilia A Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 131. Asia Acquired hemophilia A Drugs Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Acquired hemophilia A Drugs Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Acquired hemophilia A Drugs Sales by Type (2021-2026) & (k units) Table 134. Asia Acquired hemophilia A Drugs Sales by Type (2027-2032) & (k units) Table 135. Asia Acquired hemophilia A Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 136. Asia Acquired hemophilia A Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 137. Asia Acquired hemophilia A Drugs Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Acquired hemophilia A Drugs Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Acquired hemophilia A Drugs Sales by Application (2021-2026) & (k units) Table 140. Asia Acquired hemophilia A Drugs Sales by Application (2027-2032) & (k units) Table 141. Asia Acquired hemophilia A Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 142. Asia Acquired hemophilia A Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 143. Asia Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia Acquired hemophilia A Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 147. Asia Acquired hemophilia A Drugs Sales by Country (2021-2026) & (k units) Table 148. Asia Acquired hemophilia A Drugs Sales by Country (2027-2032) & (k units) Table 149. Asia Acquired hemophilia A Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 150. Asia Acquired hemophilia A Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 151. Japan Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 152. South Korea Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 153. India Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 154. Australia Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 155. Taiwan Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 157. SAMEA Acquired hemophilia A Drugs Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Acquired hemophilia A Drugs Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Acquired hemophilia A Drugs Sales by Type (2021-2026) & (k units) Table 160. SAMEA Acquired hemophilia A Drugs Sales by Type (2027-2032) & (k units) Table 161. SAMEA Acquired hemophilia A Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 162. SAMEA Acquired hemophilia A Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 163. SAMEA Acquired hemophilia A Drugs Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Acquired hemophilia A Drugs Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Acquired hemophilia A Drugs Sales by Application (2021-2026) & (k units) Table 166. SAMEA Acquired hemophilia A Drugs Sales by Application (2027-2032) & (k units) Table 167. SAMEA Acquired hemophilia A Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 168. SAMEA Acquired hemophilia A Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 169. SAMEA Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA Acquired hemophilia A Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. SAMEA Acquired hemophilia A Drugs Sales by Country (2021-2026) & (k units) Table 174. SAMEA Acquired hemophilia A Drugs Sales by Country (2027-2032) & (k units) Table 175. SAMEA Acquired hemophilia A Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 176. SAMEA Acquired hemophilia A Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 177. Brazil Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 178. Argentina Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 179. Chile Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 180. Colombia Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 181. Peru Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 183. Israel Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 184. UAE Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 185. Turkey Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 186. Iran Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 187. Egypt Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Acquired hemophilia A Drugs Distributors List Table 191. Acquired hemophilia A Drugs Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Acquired hemophilia A Drugs Image Figure 2. Global Acquired hemophilia A Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acquired hemophilia A Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 200IU Image Figure 5. 250IU Image Figure 6. Global Acquired hemophilia A Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Acquired hemophilia A Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Global Acquired hemophilia A Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Acquired hemophilia A Drugs Revenue (2021-2032) & (US$ Million) Figure 12. Global Acquired hemophilia A Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Acquired hemophilia A Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Acquired hemophilia A Drugs Revenue Market Share by Region (2021-2032) Figure 15. Global Acquired hemophilia A Drugs Sales (2021-2032) & (k units) Figure 16. Global Acquired hemophilia A Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Acquired hemophilia A Drugs Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Acquired hemophilia A Drugs Sales YoY (2021-2032) & (k units) Figure 19. Europe Acquired hemophilia A Drugs Sales YoY (2021-2032) & (k units) Figure 20. China Acquired hemophilia A Drugs Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Acquired hemophilia A Drugs Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Acquired hemophilia A Drugs Sales YoY (2021-2032) & (k units) Figure 23. Global Acquired hemophilia A Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Acquired hemophilia A Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Acquired hemophilia A Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Acquired hemophilia A Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Acquired hemophilia A Drugs Revenue Market Share by Type (2021-2032) Figure 29. Global Acquired hemophilia A Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Acquired hemophilia A Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Acquired hemophilia A Drugs Sales Market Share by Type (2021-2032) Figure 32. Global Acquired hemophilia A Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Acquired hemophilia A Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Acquired hemophilia A Drugs Revenue Market Share by Application (2021-2032) Figure 35. Global Acquired hemophilia A Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Acquired hemophilia A Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Acquired hemophilia A Drugs Sales Market Share by Application (2021-2032) Figure 38. North America Acquired hemophilia A Drugs Revenue Share by Type (2021-2032) Figure 39. North America Acquired hemophilia A Drugs Sales Share by Type (2021-2032) Figure 40. North America Acquired hemophilia A Drugs Revenue Share by Application (2021-2032) Figure 41. North America Acquired hemophilia A Drugs Sales Share by Application (2021-2032) Figure 42. North America Acquired hemophilia A Drugs Revenue Share by Country (2021-2032) Figure 43. North America Acquired hemophilia A Drugs Sales Share by Country (2021-2032) Figure 44. Europe Acquired hemophilia A Drugs Revenue Share by Type (2021-2032) Figure 45. Europe Acquired hemophilia A Drugs Sales Share by Type (2021-2032) Figure 46. Europe Acquired hemophilia A Drugs Revenue Share by Application (2021-2032) Figure 47. Europe Acquired hemophilia A Drugs Sales Share by Application (2021-2032) Figure 48. Europe Acquired hemophilia A Drugs Revenue Share by Country (2021-2032) Figure 49. Europe Acquired hemophilia A Drugs Sales Share by Country (2021-2032) Figure 50. China Acquired hemophilia A Drugs Revenue Share by Type (2021-2032) Figure 51. China Acquired hemophilia A Drugs Sales Share by Type (2021-2032) Figure 52. China Acquired hemophilia A Drugs Revenue Share by Application (2021-2032) Figure 53. China Acquired hemophilia A Drugs Sales Share by Application (2021-2032) Figure 54. Asia Acquired hemophilia A Drugs Revenue Share by Type (2021-2032) Figure 55. Asia Acquired hemophilia A Drugs Sales Share by Type (2021-2032) Figure 56. Asia Acquired hemophilia A Drugs Revenue Share by Application (2021-2032) Figure 57. Asia Acquired hemophilia A Drugs Sales Share by Application (2021-2032) Figure 58. Asia Acquired hemophilia A Drugs Revenue Share by Country (2021-2032) Figure 59. Asia Acquired hemophilia A Drugs Sales Share by Country (2021-2032) Figure 60. SAMEA Acquired hemophilia A Drugs Revenue Share by Type (2021-2032) Figure 61. SAMEA Acquired hemophilia A Drugs Sales Share by Type (2021-2032) Figure 62. SAMEA Acquired hemophilia A Drugs Revenue Share by Application (2021-2032) Figure 63. SAMEA Acquired hemophilia A Drugs Sales Share by Application (2021-2032) Figure 64. SAMEA Acquired hemophilia A Drugs Revenue Share by Country (2021-2032) Figure 65. SAMEA Acquired hemophilia A Drugs Sales Share by Country (2021-2032) Figure 66. Acquired hemophilia A Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Acquired hemophilia A Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 200IU
  • 250IU
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Sobi
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Acquired hemophilia A Drugs Market by Type
  3. 1.2.1 Global Acquired hemophilia A Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 200IU
  5. 1.2.3 250IU
  6. 1.3 Acquired hemophilia A Drugs Market by Application
  7. 1.3.1 Global Acquired hemophilia A Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Acquired hemophilia A Drugs Market Dynamics
  1. 2.1 Acquired hemophilia A Drugs Industry Trends
  2. 2.2 Acquired hemophilia A Drugs Industry Drivers
  3. 2.3 Acquired hemophilia A Drugs Industry Opportunities and Challenges
  4. 2.4 Acquired hemophilia A Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Acquired hemophilia A Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Acquired hemophilia A Drugs Revenue by Region
  3. 3.2.1 Global Acquired hemophilia A Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Acquired hemophilia A Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Acquired hemophilia A Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Acquired hemophilia A Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Acquired hemophilia A Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Acquired hemophilia A Drugs Sales by Region
  9. 3.4.1 Global Acquired hemophilia A Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Acquired hemophilia A Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Acquired hemophilia A Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Acquired hemophilia A Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Acquired hemophilia A Drugs Revenue by Manufacturers
  2. 4.1.1 Global Acquired hemophilia A Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Acquired hemophilia A Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Acquired hemophilia A Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Acquired hemophilia A Drugs Sales by Manufacturers
  6. 4.2.1 Global Acquired hemophilia A Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Acquired hemophilia A Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Acquired hemophilia A Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Acquired hemophilia A Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Acquired hemophilia A Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Acquired hemophilia A Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Acquired hemophilia A Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Acquired hemophilia A Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Acquired hemophilia A Drugs Market CR5 and HHI
  16. 4.8.2 2025 Acquired hemophilia A Drugs Tier 1, Tier 2, and Tier 3
5 Acquired hemophilia A Drugs Market by Type
  1. 5.1 Global Acquired hemophilia A Drugs Revenue by Type
  2. 5.1.1 Global Acquired hemophilia A Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Acquired hemophilia A Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Acquired hemophilia A Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Acquired hemophilia A Drugs Sales by Type
  6. 5.2.1 Global Acquired hemophilia A Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Acquired hemophilia A Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Acquired hemophilia A Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Acquired hemophilia A Drugs Price by Type
6 Acquired hemophilia A Drugs Market by Application
  1. 6.1 Global Acquired hemophilia A Drugs Revenue by Application
  2. 6.1.1 Global Acquired hemophilia A Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Acquired hemophilia A Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Acquired hemophilia A Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Acquired hemophilia A Drugs Sales by Application
  6. 6.2.1 Global Acquired hemophilia A Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Acquired hemophilia A Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Acquired hemophilia A Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Acquired hemophilia A Drugs Price by Application
7 Company Profiles
  1. 7.1 Sobi
  2. 7.1.1 Sobi Company Information
  3. 7.1.2 Sobi Business Overview
  4. 7.1.3 Sobi Acquired hemophilia A Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sobi Acquired hemophilia A Drugs Product Portfolio
  6. 7.1.5 Sobi Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Acquired hemophilia A Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Acquired hemophilia A Drugs Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Acquired hemophilia A Drugs Market Size by Type
  2. 8.1.1 North America Acquired hemophilia A Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Acquired hemophilia A Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Acquired hemophilia A Drugs Price by Type (2021-2032)
  5. 8.2 North America Acquired hemophilia A Drugs Market Size by Application
  6. 8.2.1 North America Acquired hemophilia A Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Acquired hemophilia A Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Acquired hemophilia A Drugs Price by Application (2021-2032)
  9. 8.3 North America Acquired hemophilia A Drugs Market Size by Country
  10. 8.3.1 North America Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Acquired hemophilia A Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Acquired hemophilia A Drugs Market Size by Type
  2. 9.1.1 Europe Acquired hemophilia A Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Acquired hemophilia A Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Acquired hemophilia A Drugs Price by Type (2021-2032)
  5. 9.2 Europe Acquired hemophilia A Drugs Market Size by Application
  6. 9.2.1 Europe Acquired hemophilia A Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Acquired hemophilia A Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Acquired hemophilia A Drugs Price by Application (2021-2032)
  9. 9.3 Europe Acquired hemophilia A Drugs Market Size by Country
  10. 9.3.1 Europe Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Acquired hemophilia A Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Acquired hemophilia A Drugs Market Size by Type
  2. 10.1.1 China Acquired hemophilia A Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Acquired hemophilia A Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Acquired hemophilia A Drugs Price by Type (2021-2032)
  5. 10.2 China Acquired hemophilia A Drugs Market Size by Application
  6. 10.2.1 China Acquired hemophilia A Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Acquired hemophilia A Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Acquired hemophilia A Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Acquired hemophilia A Drugs Market Size by Type
  2. 11.1.1 Asia Acquired hemophilia A Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Acquired hemophilia A Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Acquired hemophilia A Drugs Price by Type (2021-2032)
  5. 11.2 Asia Acquired hemophilia A Drugs Market Size by Application
  6. 11.2.1 Asia Acquired hemophilia A Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Acquired hemophilia A Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Acquired hemophilia A Drugs Price by Application (2021-2032)
  9. 11.3 Asia Acquired hemophilia A Drugs Market Size by Country
  10. 11.3.1 Asia Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Acquired hemophilia A Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Acquired hemophilia A Drugs Market Size by Type
  2. 12.1.1 SAMEA Acquired hemophilia A Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Acquired hemophilia A Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Acquired hemophilia A Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Acquired hemophilia A Drugs Market Size by Application
  6. 12.2.1 SAMEA Acquired hemophilia A Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Acquired hemophilia A Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Acquired hemophilia A Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Acquired hemophilia A Drugs Market Size by Country
  10. 12.3.1 SAMEA Acquired hemophilia A Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Acquired hemophilia A Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Acquired hemophilia A Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Acquired hemophilia A Drugs Value Chain Analysis
  2. 13.1.1 Acquired hemophilia A Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Acquired hemophilia A Drugs Production Mode & Process
  6. 13.2 Acquired hemophilia A Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Acquired hemophilia A Drugs Distributors
  9. 13.2.3 Acquired hemophilia A Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst